World Journal of Urology

, 27:189 | Cite as

Radiation therapy in the management of the primary penile tumor: an update

Topic Paper



Squamous carcinoma of the penis is rare but psychologically devastating and potentially fatal. Radiotherapy offers a penile-conserving treatment option without jeopardizing cure. We have used primary penile brachytherapy as the treatment of choice for T1, T2 and selected T3 patients since 1989 and present updated results for 67 patients.


Mean age was 60 years (range 22–93). Stage was T1 in 56%, T2: 33%, T3: 8%, and Tx: 3%. Grade was moderate or poorly differentiated in 48%. In Toronto after-loading pulse dose rate (PDR) brachytherapy (n = 41) was used for all treatments while Ottawa used manually loaded Iridium192 (n = 26). Two or three parallel planes of needles (median 6) were inserted using pre-drilled lucite templates for guidance and fixation; 60 Gy was delivered over 4–5 days.


Median follow-up is 4 years (range 0.2–16.2). At 10 years, actuarial overall survival is 59%, cause specific survival 83.6%. Nine men died of penile cancer and eight of other causes with no evidence of recurrence. Penectomy was required for eight local failures and two necroses, for an actuarial penile preservation rate at 5 years of 88% and 10 years of 67%. The soft tissue necrosis rate is 12% and the urethral stenosis rate 9%. Six of 11 regional failures were salvaged by lymph node dissection ± external radiation. The other five all had concurrent distant failure and died of disease.


Brachytherapy is an effective treatment for T1, T2 and selected T3 SCC of the penis. Close follow-up is mandatory as local failures and many regional failures can be salvaged by surgery.


Squamous carcinoma of penis Brachytherapy Radiotherapy 


  1. 1.
    Opjordsmoen S, Fossa SD (1994) Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol 74:652–657PubMedCrossRefGoogle Scholar
  2. 2.
    Ornellas AA, Seixas AL, Marota A et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151:1244–1249PubMedGoogle Scholar
  3. 3.
    Harden SV, Tan LT (2001) Treatment of localized carcinoma of the penis: a survey of current practice in the UK. Clin Oncol (R Coll Radiol) 13:284–287 quiz 288Google Scholar
  4. 4.
    Crook J, Grimard L, Tsihlias J et al (2002) Interstitial brachytherapy for penile cancer: an alternative to amputation. J Urol 167:506–511PubMedCrossRefGoogle Scholar
  5. 5.
    Sobin LH (2002) WC: Penis (ICD-0 C60) in TNM classification of malignant tumours, 6th edn. Wiley, New YorkGoogle Scholar
  6. 6.
    Pierquin B, Chassagne D, Wilson F (1987) Modern brachytherapy. Masoom Pub, New YorkGoogle Scholar
  7. 7.
    Armour EP, White JR, Armin A et al (1997) Pulsed low dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys 38:825–834PubMedCrossRefGoogle Scholar
  8. 8.
    Chen CZ, Huang Y, Hall EJ et al (1997) Pulsed brachytherapy as a substitute for continuous low dose rate: an in vitro study with human carcinoma cells. Int J Radiat Oncol Biol Phys 37:137–143PubMedGoogle Scholar
  9. 9.
    Fowler JF, Van Limbergen EF (1997) Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 37:877–883PubMedGoogle Scholar
  10. 10.
    Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457CrossRefGoogle Scholar
  11. 11.
    Pepe MS, Mori M (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737–751PubMedCrossRefGoogle Scholar
  12. 12.
    Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMedGoogle Scholar
  13. 13.
    McLean M, Akl AM, Warde P et al (1993) The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 25:623–628PubMedGoogle Scholar
  14. 14.
    Soria JC, Fizazi K, Piron D et al (1997) Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 8:1089–1098PubMedCrossRefGoogle Scholar
  15. 15.
    Rozan R, Albuisson E, Giraud B et al (1995) Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol 36:83–93PubMedCrossRefGoogle Scholar
  16. 16.
    Zouhair A, Coucke PA, Jeanneret W et al (2001) Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis? Eur J Cancer 37:198–203PubMedCrossRefGoogle Scholar
  17. 17.
    Sarin R, Norman AR, Steel GG et al (1997) Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 38:713–722PubMedCrossRefGoogle Scholar
  18. 18.
    Sagerman RH, Yu WS, Chung CT et al (1984) External-beam irradiation of carcinoma of the penis The treatment of early cancer of the penis with megavoltage x-rays. Radiology 152:183–185PubMedGoogle Scholar
  19. 19.
    Vujovic Olga GJB (2001) Davis Stewart: carcinoma of the penis: a treatment technique with external beam radiation. Ann R Coll Physicians Surg Can 34:495–497Google Scholar
  20. 20.
    Mazeron JJ, Langlois D, Lobo PA et al (1984) Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970–1979). Int J Radiat Oncol Biol Phys 10:1891–1895PubMedGoogle Scholar
  21. 21.
    Kiltie AE, Elwell C, Close HJ et al (2000) Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Clin Oncol (R Coll Radiol) 12:25–31Google Scholar
  22. 22.
    Delannes M, Malavaud B, Douchez J et al (1992) Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 24:479–483PubMedGoogle Scholar
  23. 23.
    Solsona E, Algaba F, Horenblas S, et al. (2008) European Association of Urology Guidelines. In: Office EG (ed) Guidelines on Penile Cancer. Arnhem, Netherlands, Drukkeril Gelderland bv pp Chapter 6:1–28Google Scholar
  24. 24.
    Chaudhary AJ, Ghosh S, Bhalavat RL et al (1999) Interstitial brachytherapy in carcinoma of the penis. Strahlenther Onkol 175:17–20PubMedCrossRefGoogle Scholar
  25. 25.
    Gotsadze D, Matveev B, Zak B et al (2000) Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 38:306–312PubMedCrossRefGoogle Scholar
  26. 26.
    Mistry T, Jones RW, Dannatt E et al (2007) A 10-year retrospective audit of penile cancer management in the UK. BJU Int 100:1277–1281PubMedCrossRefGoogle Scholar
  27. 27.
    Neave F, Neal AJ, Hoskin PJ et al (1993) Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin Oncol (R Coll Radiol) 5:207–210Google Scholar
  28. 28.
    Ozsahin M, Jichlinski P, Weber DC et al (2006) Treatment of penile carcinoma: to cut or not to cut? Int J Radiat Oncol Biol Phys 66:674–679PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of Toronto, Princess Margaret Hospital, University Health NetworkTorontoCanada
  2. 2.Department of BiostatisticsPrincess Margaret HospitalTorontoCanada
  3. 3.Department of Radiation OncologyOttawa Cancer CenterOttawaCanada

Personalised recommendations